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SUMMARY : Ischemic-reperfusion injury caused by oxygen-drived free radicals 
is one of the great problems to be solved for successful lung transplantation and 
preservation. This study was performed to clarify the effect of the free radical 
scavenger, reduced glutathione (GSH), superoxide dismutase (SOD), and alloprinol 
for warm ischemic lung, and to elucidate changes of active oxygen species production 
in neutrophils. 
<Method > Sixty-three mongrel dogs underwent hilar stripping following left 
thoracotomy. The left pulmonary artery, pulmonary vein, and left main bronchus 
were clamped for 2-3 hours. To reduce the free-oxygen radicals, alloprinol (30mg/kg 
/day, for 3 days peros), GSH (50mg/kg, I. V.) administration and perfusion through
the　 pulmonary.　 artery　 with　 4℃ 　Euro-Collins'solution　 including　 GSH(1mg/l),　 SOD
(15mg/ml), and alloprinol (20mg/l) were performed. At the time of right pulmonary 
artery occlusion test, the blood gas analysis of arterial blood and measurement of 
left pulmonary arterial pressure were done on the pre-ischemic period, immediately 
after and one hour after declamping. 
   At the same time, active oxygen species production in neutrophils was evaluated 
using flow cytometric procedure. 
<Results> 1) The good pulmonary gas-changing function remained after ischemic 
period by administration and perfusion with free radical scavenger GSH, SOD, and 
alloprinol. 
2) Changes of pulmonary arterial pressure at right pulmonary artery occulision test 
was not statistically significant. 
3) Production of active oxynene species in neutrophils was increased after ischemic 
period. 
   In conclusion, all of GSH, SOD, and alloprinol are effective in elminating ische-
mia-reperfusion injury to warm ischemic lung.
       INTRODUCTION 
 Since 1965, clinical application of lung trans-
plantation has been made in 3 patients in 
Japan.1) 2) However, its outcome failed to 
obtain long survival due to immunologic rejec-
tion. On the contrary, in Europe and the united 
states of America there are quite a few pro-
longed survivors following transplantation 
including renal transplantation with an did of 
development of cyclosporine A.3) 
 Therefore, reperfusion injury is a great 
concern to success of clinical lung transplanta-
tion except for immunologic response. There 
are many reports in the pathogenesis of reper-
f usion syndrome. Great concern is focused on 
an activation of active oxygen species 4) 5) 6) to
prevent damage to warm ischemic donor lung. 
The purpose of this study is to clarify the role 
of free radical scavenger such as GSH, SOD 
and alloprinol to elimenate reperfusion injury 
at transplantation by means of an evaluation 
of inhibited generation of free radical in 
peripheral neutrophils. 
    MATERIAL AND METHOD 
1) Animal 
 Sixty-three Mongrel dogs weighing from 8 to 
14 kg in body weight were used. All dogs were 
supplied from Laboratory Animal Center for 
Biomedical Reserch, Nagasaki University 
School of Medicine. 
2) Experimental Method 
 Dogs were anesthetized with 25mg/kg of 
pentobarbital sodium, intubated intratracheally 
and ventilated with Harvard Ventilator, 250-
350m1 in tidal volume, 12-14/min in respira-
tory rate. Cannulation into the femoral artery 
was performed to measure the systemic blood 
pressure continuously. Left thoracotomy was 
made at the 5th ICS. The left main pulmonary 
artery and left main bronchus were isolated 
from the surrounding tissue. A procedure of 
hilar stripping , which is composed of dividing 
branches of the vagus, bronchial artery and 
lymphatic channels. 
 After heparization of 100mg/kg, the left 
main pulmonary artery, vein and left main 
bronchus were separately clamped to make a 
model of warm ischemic lung for 2- 3 hours. 
After ralease of clamps with elapsed time of 2-
3 hours blood flow was recirculated. In in-
fusion groups prior to restart of blood flow, 
a small catheter (1.9 mm I.D.) was introduced 
into the pulmonary artery to monitor the 
infusion pressure of 40cmH2O and also a small 
hole was made in the left atrial wall so as to 
allow perfusate to flow out. 
 At the time of completion of perfusion prior 
to restoration of blood circulation, the 
monitoring catheter was withdrawn and the 
left atrial wall was repaired. 
 At the first hour following blood recircula-
tion, PA pressure was measured and blood 
samples from PA, PV and femoral A were pre-
pared for blood gas analysis and assessment of 
free radical in neutrophils. 
3) Measurement of generation of free radical 
 in neutrophils. 
 The measurement was in accordance with 
modified Bass' method 7 ) (Fig. 1) by using 
Spectrum III (ORTHO Co. ). As a stimulator 
to neutrophils, phorbol myristate acetate 
(PMA) was used.
Fig. 1. Principle of evaluation of active oxygen 
       species production
 Measurement steps> 
1) 0.1ml Blood samples were taken, 1.9m1 of 
0.5M 2-7-dichlorofluorescin diacetate (DCFH-
DA) was added, incubated at 37°C for 15 min. 
2) 0.5ml of EDTA adjusted to 24mM with 
PBS were added to prevent aggregation of 
neutrophils. 
3) and incubated at 37°C for 25 min in addi-
tion to 10u1 of PMA (15,ug/ml) 
4) washed with PBS and centrifused at 1300 
rpm for 10 min. 
5) hemolysed with lysing solution of 0.87% 
NH4 Cl 
6) washed with PBS and centrifused at 1300 
rpm for 10 min 
7) the pellet is suspended with 10% gel-Hanks'
solution 
8) analysed with the use of spectrum III. As a 
negative control, the peripheral blood from a 
dog was used and the positive zone (13%) was 
adjusted to be 2-5% of B-start at the resting 
phase and generation of active oxygen species 
was calculated as being 13% after stimulation 
with PMA. 
 Experimental groups 
 The groups in the experiment were divided 
into 7. 
group I : simple warm ischemia (n= 13) 
group II : intravenously given GSH (50mg/kg) 
at induction of anesthesia and prior to recircu-
lation (n=8) 
group III : orally given alloprinol (30mg/kg) 
3 days before the experiment (n=10) 
group IV : perfusion group with Euro-Collins' 
solution (E-C solution) (n=8) 
group V : perfusion group with E-C solution 
+GSH (1mg/ml) (n=8) 
group VI : perfusion group perfused with E-C 
solution+SOD (15mg/l) (n=8) 
group VII : group perf used with E-C solution + 
Alloprinol (20mg/l) (n=8). (Alloprinol suppli-
ed from Jap Welcome Co.) 
 Statistical analysis 
  The values were expressed as the means ± 
standard deviation (SD). The difference among 
means was determined to be significant with 
Wilcoxon-t test. 
          RESULTS 
1) PA pressure (Table 1, Fig. 2) 
  The PA pressures in all groups were elevated 
after temporary contralateral PA blockage. 
There was no statistically significant diffe-
Fig. 2. Pulmonary artlrial pressure after rt PA 
       occulusion test
rence among the groups. 
2) arterial Pa02 (Table 2, Fig. 3) 
 The levels of pa02 in group II, III were supe-
rior to that in group I and also those in group 
V, VI, VII were better than in group IV imme-
diately and one hour after restoration of blood 
circulation. Statistically significant differences 
were calculated in group II immediately after 
and one hour after and in group III immediately 
after recirculation (P<0.05) and in group III 
one hour after recirculation (p<0.01) and as 
compared with the control in group V, VII one 
hour after (p<0.05) respectively. 
3) arterial PaCO2 (Table 3, Fig. 4) 
  The levels of PaCO2 were increased by tempo-
rary contralateral PA block test. Its grade of 
group II III and Group V VI VII was depressed 
as compared with that of group I and IV, in 
particular there is significant difference bet-
ween group II , V and the control groups.
                     Table 1. Pulmonary arterial pressure (mmHg) 
                   group I group II group III group IV group V group VI group VII 
   pre-ischemia 19.7± 9.0 21.7± 4.1 18.4± 4.8 19.5± 2.8 19.0± 4.0 20.8± 5.7 21.6± 4.7 
  r. PA occ. pre. 30.1± 6.5 30.4± 3.8 29.6± 6.2 27.9± 3.3 27.9± 4.1 29.9± 7.3 31.3± 5.2 
 immediately after 20.6± 7.8 18.9± 4.2 19.8± 5.6 19.8± 2.9 18.9± 3.8 22.1± 7.9 21.1± 3.9 
r. PA occ. im. after 31.1±11.7 27.4± 5.6 28.3± 4.7 33.1± 4.2 29.3± 4.6 31.4± 7.3 30.6± 6.1 
    1 Hr after 22.6± 8.0 20.6± 4.6 20.8± 5.6 20.0± 3.8 19.0± 3.1 23.9± 5.4 20.6± 3.0 
r. PA occ. -1Hr after 31.4±12.2 27.0± 5.1 28.9± 5.5 30.4± 5.6 26.3± 6.0 34.0± 6.8 29.5± 6.7
                        Table 2. Blood gas alalysis-Pa02- (mmHg) 
                 group I group II group III group IV group V group VI group VII 
   pre-ischemia 424.9± 75.5 455.8± 48.4 473.5± 58.3 469.5± 46.3 441.0±113.2 462.8± 32.1 459.7± 67.2 
  r. PA occ. pre. 223.4±109.3 230.4±106.0 312.6±164.0 275.3±103.5 249.0± 90.6 222.8±126.3 177.3±112.3 
immediately after 357.7± 97.4 495.5±102.8 438.6±136.6 452.7±136.3 440.8±132.6 399.7±100.7 459.9±141.9 
r. PA occ. im. after 86.4± 44.2 225.2±118.3 236.4±166.0 193.5±113.9 252.3±138.9 230.4±109.7 294.7±151.9 
   1 Hr after 155.3± 88.8 356.2±173.2 390.0±119.1 340.3± 85.3 373.0±104.2 354.4±116.6 367.5±184.7 
r. PA occ. -1Hr after 92.0± 30.8 182.6± 97.6 215.0±100.0 113.6± 47.3 237.6±155.2 198.9±148.0 232.5±184.5
Fig. 3. Pa02 after rt PA occulusion test
Fig. 4. PaC02 after rt PA occultsion test
                     Table 3. Blood gas analysis-pressure (mmHg) 
                   group I group II group III group N group V . group VI group VII 
   pre-ischemia 26.9± 9.3 17.9± 3.3 18.9± 4.3 19.2± 2.1 18.4± 5.0 18.2± 5.5 18.2± 3.1 
  r. PA occ. pre. 25.7± 6.9 26.1± 6.7 22.2± 6.5 25.4± 4.3 25.5± 8.4 24.7± 6.4 24.8± 6.8 
 immediately after 23.8± 6.4 19.9± 4.7 19.5± 5.0 23.3± 7.6 19.4± 4.4 20.3± 5.1 19.2± 5.1 
r. PA occ. im. after 33.2± 7.3 24.5± 6.1 23.9± 8.4 28.4± 6.5 26.2± 7.1 25.3± 5.9 26.1± 8.5 
    1 Hr after 29.2± 8.7 22.1± 5.7 22.4± 6.3 27.3± 6.4 22.2± 4.0 23.2± 4.4 23.9± 7.5 
r. PA occ. -1Hr after 36.0± 5.1 25.8± 5.6 27.0± 8.8 31.5± 4.9 25.1± 6.0 26.8± 7.3 25.5± 8.5
4) Intrapulmonary shunt (Table 4, Fig 5) 
 The intrapulmonary shunting rate was 
calculated as the following equation8), Qs/Qt 
=0 .03 (PAO2 -PaO2) /4.5+0.003 (PAO2 -
Pa02 ), wherein Fi02 = 1, Sa02 = 100%, Ca02 -
Cv02 =4.5 vol%. 
 The intrapulmonary shunting rates were 
figured out during performing temporary 
contralateral PA block test Intrapulmonary
shunt lessened in groups in which protective 
drugs for storaged lungs were used, in parti-
cular, were of great benefit in group II imme-
diately and one hour after recirculation (P 
0.01). 
5) Generation of free radical in neutrophils 
 (Table 5, Fig. 6) 
 Fig. 7 revealed a cytogram of Spectrum III , in
                      Table 4. Blood gas analysis-shut ratio- (%) 
                  group I group II group III group IV group V group VI group VII 
  pre-ischemia 23.32±2.97 23.04±4.10 22.53±5.22 20.32±3.67 22.27±3.73 23.20±5.33 25.03±4.17 
immediately after 28.10±1.36 23.17±4.63 25.23±4.75 24.71±4.63 21.92±5.64 22.96±4.34 20.12±6.20 
   1 Hr after 27,80±0.99 24.95±3.67 24.94±1.46 27.47±1.52 22.46±6.55 23.96±5.80 22.65±8.15
Fia. 5. Intrapulmonary shunt Fig. 6. Generation of free radical in neutrophils
Table 5. Production of active oxygene species by PMN (%)
                  group I group II group III group IV group V group VI group VII 
pre-ischemia (PA) 72.7±12.0 73.1±'16.8 67.3±15.7 71.0±12.9 77.8±12.4 79.2±10.7 72.0±13.3 
pre-ischemia (PV) 72.9±12.1 73.1±14.8 64.7±12.3 69.8±14.1 80.9± 5.5 79.9±11.1 70.7±10.7 
immed. after (PA) 83.0± 9.3 86.9± 6.6 73.6± 9.8 82.0±14.8 81.3±10.3 89.3± 4.8 80.9±11.9 
immed. after (PV) 81.9± 9.6 86.4± 4.3 76.0±12.4 80.7±14.1 81.7± 9.8 87.5± 6.4 83.7±11.8 
 1 Hr after (PA) 81.5±10.7 90.3± 3.1 78.1± 7.2 83.1±12.4 80.9±13.9 85.6± 6.9 82.8± 8.9 
 1 Hr. after (PV) 81.1±10.2 92.9± 1.8 80.1± 5.9 77.5±16.6 86.7±11.5 87.0± 6.7 79.9±13.5
which the ordinate represented the. size of 
cells obtained by the foward light scatter 
method, on the other hand, the abscissa present-
ed inner structure of cells obtained by the 90 
degree light scatter method. 
 Fig. 8-A demonstrated a histogram at the 
resting states and Fig. 8-B showed a histogram 
after stimulation by PMA. It showed that 
neutophils distributed regularily. In every 
group, generation of free radical was accerelat-
ed after ischemia. However, there was no 
significant difference in generation of free 
radical. between the blood sumpling from
pulmonary arteries and veins. 
 As compared with the control, generation of 
free radical one hour after recirculation was 
pronounced in group II , although there was no 
definite difference in the other groups. 
        DISCUSSION 
 Since lung transplantation has first been 
made in clinical application by HAY9), scores 
of patients were reported. However, cyclo-
sporin offered insight into the significant 
effect on suppression of immune response. In
based on increased permeability of the vessel 
wall and subsequent edema. Furthermore 
cytotoxic ferment breaks away from the inside 
of cells to the blood. 
 On the other hand, it is accepted that reper-
fusion injury is mainly caused by free radicals. 
4)-6) 10) 11) 
 WEISS 10) suggested that main damage to 
cellular structure and function is associated 
with action of free radicals. HAGLUND et al 11) 
suggested that organ damage of storage lungs 
is due to not only ischemia but reoxygenation. 
JACKSON et a112) reported that free radicals 
allow destruction of protein, membrane and 
nucleic acid and causes stagnation, incomplete 
reexpansiori of donor lung, thickness of alveo-
lar septum and fibrosis in the pulmonary 
parenchym. 
 A damage to a donor lung caused by free 
redicals offers a great problem on ischemia
Fig., 7. Cotogram of spectum I
Fig. 8-A Histogram of spectum III 
         (Resting)
consequence Copper reported prolonged survi-
vors with lung allograft in clinical use. 
 To expect an adequate function of lung 
allografts immediately after lung transplanta-
tion, reperfusion injury should be minimized 
during storage of a donor lung. MCCORD4) ex-
plains that ischemic damage to a donor -lung is
Fig. 8-B. Histogram of spectrum III 
      (PMA stimulation)
during storage of a donor lung and restoration 
of blood circulation after completion of 
transplantation procedure. 
 Lung edema which takes place in early stage 
after lung transplantation is referred as 
reimplantation response 13) 14) and main cause 
is ischemia and denervation. However, it still
remains unsettled. 
<Alloprinol> 
 In 1968 Mcconn 15) pointed out that most 
important source of free radicals is xanthine 
oxidase system as shown in Fig. 916), when the 
reactions of ATP, ADP, AMP to hypoxanthine 
progress, 02 supply by blood recirculation 
makes 02 - by a reaction of hypoxanthine to 
Xanthine. It needs for Xanthine oxidase (XOD) 
which contains abundantly in organs. 
 Alloprirol is an inhibitor of XOD, which is 
used for gout. 
 There are some reports on the effects of 
alloprinol with respect to the heart4) 17) 18) 
small interstine4) 19) and liver4 ), although it is 
scanty concerning the lung. 
 HASImvIOTO 20) reported that XOD activities 
in various organs are as follows, 19.5munit/g 
in the brain, 240.0 'in the liver, 185.1 in the 
lung, 26.3 in the heart, 225.4 in the spleen, 
122.3 in the kidney 630.4 in the pancreas 708.0 
in the small intestine 95.2 in the colon 147.2 in 
the adrenal grand respectively. KINASEWITZ 21) 
also cited that alloprinol effectively inhibited 
increased permeability of vessel walls in the 
pulmonary capillary. From the facts, alloprinol 
is one of the effective inhibitors against 
ischemia and reperfusion injury. 
 It is well known that the protective role of
alloprinol in ischemia and reperfusion injury is 
required for alteration to oxyprinol in vivo 
and it consumes some time interval. Therefore, 
it is recommended that alloprinol should be 
administered in advance. 
 In this study, it is substantiated that the 
use of alloprionl prior to 3 days is of great 
benefit to eliminate damage of ischemia and 
reperfusion injury to a donor lung as compared 
with the control and a result of group Vm 
which was intraoperatively perf used with 
protective drugs. 
<GSH> 
 GSH acts as one of radical scavengers and 
cooperates with glutathione perioxidase (GSH-
Px) to eliminate an action of active oxygen 
species22) 26 ), which deals with H202 in the 
cells and/or mitochondria 23) and plays a key 
role in acting as ground substance24) with an 
aid of NADPH and NADH actions (Fig. 10). 
 In the hypoxic circumstances, a shortage of 
ATP supply results in a decrease in GSH 
synthesis and a delay in dealing with active 
oxygen species. 25) It is a confirmed fact that 
hypoxia in the brain reduces the amount of 
GSH 27), and it is suggested that GSH plays an 
important role in removing active oxygen 
species. 
 On the other hand, it is well known that a
Fig. 9. Reaction of Xanthine
Fig. 10. Reaction of glutathione
shortage of GSH in the lung facilitates oxygen 
intoxication. 28) 
 DAwsoN29) explained a merit of the use of 
exogenous GSH in the experiments of isolated 
lung and/or isolated lung cells in the hypoxic-c 
ircumstances to prevent is chemic damage to 
pulmonary parenchym. It is also clarified that 
damage to the epithelial cells of the gut is 
protected by exgenous GSH, and administration 
of GSH contributes to elimination of active 
oxygen species. 30) 
 It is dubious as to whether intravenous 
administration of GSH is absorbed in the 
reticuloendothelial system or not. It is accepted 
that the half life of GSH is just 3 min and its 
action reduces to 90% at 10 min and during 
that time the content of GSH in the liver and 
kidney does not vary in rats. In human being 
the half life is 2 min when given intravenously 
and it is quickly metabolized. 
 When GSH is dissolved, it converts into 
three amino-acids of cystine, glycine and 
glutamic acid and is resynthesized to GSH in 
the liver and carried via blood circulation. 
 In this study, it is ascertained that GSH is 
of great help to reduce ill effects of ischemic 
damage and reperfusion injury on a storage 
lung. The reasons are due to direct protective
action of GSH and/or resynthesized GSH in 
the liver from amino-acids of dissolved GSH. 
 It is said that antioxidation by the help of 
GSH is established with GSH, intracellularily 
synthesized, which plays a key role in contri-
buting to dealing with glutathione peroxidase 
(GSH-Px) in the plasma.') 32) 
<SOD> 
 Since MCCORD et a133) discovered SOD in 1969, 
advances in basic study on SOD have been 
established. SOD includes the types of Mn, Fe 
and Cu, Zn. In mammalias, SOD exists in the 
Cu, Zn type in the cells and the Mn type in the 
mitochondria. 
 In the human body, SOD is distributed in 
varying patterns 34) (Table. 6). The main action 
is promotion of a reaction from 02 to H202. 
Therefore, final product of 02 should be re-
moved in humans. 
 SOD increases with advancing age. However, 
this tendency toward an increase in SOD is 
much more potent in neonates than in older 
patients35 ). In the experiment with the rat 
lung which has high resistance to oxygen 
activity, the following fact is clarified that 
type II alveolar cells increase in number and 
SOD is activated at the same time3s) 
 However, it is doubtful if intravenous
Table. 6. Cu, Zu-SOD and Mn-SOD in human 
        organs (mg/kg) 
                 Cu, Zn-SOD Mn-SOD 
liver 490 390 
lung 254 25 
kidney (cortex) 164 142 
RBC 157 0 
uterus 148 26 
brain 136 55 
heart 119 97 
muscle 107 52 
thyroid 103 65 
testis 76 22 
spleen 71 22 
lymph node 58 71 
fatty tissue 8 3
administration of SOD is helpful to reduce 02 
intoxication because of a short half time. It is 
reported that 55 % of SOD is excreted in the 
urine 2 hours after I. V. administration and 29 
% accumulates in the renal cortex37 ). In this 
study, direct administration by perfusion was 
performed to maintain its action as long as 
possible in order to expect a role of SOD. 
 Needless to say, there are many devices to 
keep long-standing action of SOD. For example, 
it is a trial product of included SOD to lipo-
some which shows a high affinity to the cell 
membrane containing a rich lipoprotein so 
that it is easy for SOD to be taken into the 
cells, and attention is paid to prolong half life 
time. FREEMAN reported that by using vascu-
lar endothelium which is highly sensitive to 
oxygen intoxication, SOD included in liposome 
provided a 95% resistance to oxygen, and it is 
confirmed that in in-vivo experiment it made 
a half time of circulating SOD prolonged and 
achieved inhibition of a 100% 02 intoxication 
with an aid of high activity of SOD. 
<Neutrophils> 
 The main source of active oxygen species is 
neutrophils. Ischemia causes active arachidon 
acid reaction and consequently free radicals 
are generated. In addition destructive product 
of fibrin, production of leukotrien B4, platelet 
activating factor (PAF) and so on activate 
neutrophile in the reaction circle of generation 
of free redicals.39) 
 In this study, the levels of free radicals were
kept high on account of stimulation of ische-
mia at the time of start of recirculation and 
by activated neutrophils at one hour after 
recirculation. The method of measuring free 
redicals according to Bass7) by using flow 
cytometry is of great benefit in terms of 
simplicity and accuracy. 
 In the experiment regarding ischemic hearts 40) 
it is reported that, when recirculation was 
performed with f ree-neutrophil blood, the 
ischemic area in the heart was reduced and 
minimized and lessened the degree of infiltra-
tion of neutrophils around the tissues by add-
ing SOD, suggesting some parts of SOD to 
neutrophils. 
 In this study, the author emphasized that 
intravenous administration of GSH offered 
insight into the effect that given GSH accele-
rates GSSG reaction circle by facilitating 
NADPH reaction, and consequently leads to an 
increase in 02 generation. 
 Needless to say, 02- generated in the body 
is eliminated by the help of GSH action, there-
fore damage of O2 is minimized. On the other 
hand, in the perfusion groups, activation of 
02 was lower than those in the other groups. 
It is more likely for GSH to be not in contact 
with the membranes of neutrophils in the 
perfusion groups. It is different from in I. 
V given groups. 
 As for the pressure of the pulmonary artery, 
it was a tendency to be lower in the groups in 
which protective drugs were used. However, it 
was of no statistical significance. It seems to 
be associated with the slight degree of reversi-
ble alteration of perivascular edema and 
thrombosis, reflecting no ominous effects on 
pulmonary vascular resistance. 
         SUMMARY 
 The study aimed at an inhibition of free 
radicals to prevent warm ischemic damage to 
a donor lung. 
1) SOD, GSH and alloprinol play a protective 
role in preventing warm ischemic damage and 
in eliminating alveolar-capillary block 
2) These drugs were significantly of no use to 
reduce the pressure of the pulmonary artery 
following lung transplantation
3 ) Generation of active oxygen species in 
neutrophils increased by an addition to 
ischemia and start of recirculation, in particu-
lar, that in the GSH-given group was much 
more prominent than those in the other groups. 
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